The function of apolipoprotein J (apoJ) is unknown, but it has been hy
pothesized to be cytoprotective. In the normal heart, abundant apoJ mR
NA and protein are expressed in atrial myocytes; no expression is dete
cted in ventricular myocytes. To provide clues about the role of apoJ
in the heart, the response of apoJ to heart disease, including three m
odels of myocarditis and two models of in vivo pressure overload hyper
trophy, were examined In the disease model studied extensively, myosin
-induced myocarditis, in situ hybridization detected induction of apoJ
mRNA in ventricular myocytes immediately before histological evidence
of injury, ApoJ message in ventricular myocytes reached high levels a
s myocarditis became more severe. Evidence of early apoJ induction, be
fore inflammation and injury, also occurred in viral myocarditis. ApoJ
mRNA was not present in the inflammatory or interstitial cells during
myocarditis. In areas of severe inflammation and myocardial fiber deg
eneration, apoJ showed a gradient of expression, with highest levels i
n myocytes immediately surrounding the lesion and diminishing with inc
reasing distance. ApoJ protein also accumulated in myocytes at the int
erface between degenerated myocardial tissue and the surrounding cardi
ac tissue During cardiac hypertrophy that occurred without associated
inflammation or cell damage, ventricular apoJ mRNA was not detected Wh
en ischemic damage accompanied hypertrophy, apoJ was induced in the ve
ntricular myocytes near the lesion borders. The correlation of apoJ in
duction with ventricular tissue damage, but not hypertrophy, suggests
that apoJ is a repair response protein. We propose that apoJ functions
to limit tissue injury and/or promote tissue remodeling.